No definite difference for primary endpoint but proven safety with ARNI in MI patients

5' education - May 15, 2021 - Prof. Marc Pfeffer, MD, PhD - Boston, MA, USA

Educational information

This video was recorded during the virtual congress of the ACC.21.

Faculty

Dr. Marc Alan Pfeffer is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Victor J. Dzau professor of medicine at Harvard Medical School, Boston, MA, USA.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of this trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.